The Journal of Neuroscience, July 16, 2003, 23(15):6238-6244
Previous Article | Next Article 
Differential Regulation of Transmitter Release by Alternatively Spliced Forms of Synaptotagmin I
Arash Nakhost,1 *
Gry Houeland,2 *
Vincent F. Castellucci,2 and
Wayne S. Sossin1
1Department of Neurology and Neurosurgery, McGill
University, Montreal Neurological Institute, Montreal, Quebec, Canada H3A 2B4,
and 2Department of Physiology, University of Montreal,
Montreal, Quebec, Canada H3C 3J7
 |
Abstract
|
|---|
We discovered a novel alternatively spliced form of synaptotagmin I (Syt
I). This splicing event is conserved over evolution and, in Aplysia,
results in a two amino acid insert in the juxtamembrane domain of Syt I (Syt
IVQ). Both Syt I and Syt IVQ are localized to synaptic
vesicles; however, we also observed punctae that contained one or the other
spliced products. Both Syt I and Syt IVQ are phosphorylated at the
adjacent PKC site. Overexpression of Syt IVQ, but not of Syt I, in
Aplysia neurons blocked the ability of serotonin to reverse synaptic
depression. This effect is upstream of PKC activation, because neither Syt
IVQ nor Syt I blocked the effects of phorbol esters on reversing
synaptic depression or the effects of serotonin on facilitating nondepressed
synapses. Our results demonstrate a physiological role for splicing in the
juxtamembrane domain of Syt I.
Key words: synaptotagmin; transmitter release; protein kinase C; PKC; Aplysia; depressed synapses; alternative splicing
 |
Introduction
|
|---|
Synaptotagmins (Syts) are membrane proteins thought to act as calcium
sensors during membrane fusion. In particular, Syt I is important for the
release of neurotransmitters from synaptic vesicles because loss of Syt I
function removes the fast Ca2+-dependent phase of
neurotransmitter release (Nonet et al.,
1993
; DiAntonio and Schwarz,
1994
; Geppert et al.,
1994
). Moreover, as would be expected from a
Ca2+ sensor, mutations that affect the
Ca2+ sensitivity of Syt I affect the
Ca2+ sensitivity of transmitter release
(Fernandez-Chacon et al., 2001
;
Mackler et al., 2002
). So far,
13 isoforms of Syts have been identified in mammals (Syt ISyt XIII), as
well as six to eight homologues in Drosophila and Caenorhabditis
elegans (for review, see Schiavo et
al., 1998
; Adolfsen and
Littleton, 2001
; Sudhof,
2002
). Syts comprise a lumenal N terminal, a transmembrane domain,
and a short juxtamembrane linker, followed by two C2 domains (C2A and C2B).
The function of synaptotagmin in membrane fusion is mediated by
proteinprotein and proteinlipid interactions of these C2 domains
(for review, see Schiavo et al.,
1998
; Adolfsen and Littleton,
2001
).
The juxtamembrane domain of Syt I is well conserved within Syt I-like
isoforms (Syt II, Syt IX, and invertebrate Syt Is) but is not conserved in
other Syts. This suggests that the juxtamembrane region may play a role in
specific functions of Syt I-like isoforms. Indeed, this segment has been
proposed to play a role in the specific cellular localization of Syts
(Fukuda et al., 2001
). The
juxtamembrane domain is also the location of all of the well characterized
sites for Syt I phosphorylation (Bennett et
al., 1993
; Davletov et al.,
1993
; Hilfiker et al.,
1999
).
Aplysia sensorimotor (SM) neuron synapses show a remarkable
synaptic depression to repeated stimulation that is thought to underlie
behavioral depression (Byrne and Kandel,
1996
). Both depression and the reversal of this depression by
serotonin (5-HT) involve regulation of the release machinery
(Byrne and Kandel, 1996
). While
recloning Aplysia Syt I to examine a possible role for Syt I
phosphorylation in regulating the reversal of depression, we discovered a
novel alternatively spliced form of this protein with two amino acids, V and
Q, added in the juxtamembrane domain. This splicing event is conserved in
Drosophila and mammalian Syt I. Overexpression of this synaptotagmin
spliced product (Syt IVQ), but not of Syt I, blocked 5-HT-mediated
reversal of depression. These results reveal the first evidence for the
importance of splicing in the juxtamembrane domain of Syt I and suggest
additional roles for Syt I in regulating membrane trafficking.
 |
Materials and Methods
|
|---|
Aplysia californica (50200 gm) were purchased from Marine
Specimens Unlimited (Pacific Palisades, CA) or the Aplysia resource
facility at the University of Miami (Miami, FL) and kept in an aquarium for at
least 3 d before experimentation. Dissections and isolation of tissues and
cultured neurons was as described previously
(Manseau et al., 2001
).
Plasmid construction. We designed exact primers to the cytoplasmic
domain of Aplysia Syt I (5', CGCGAATTCAAGAAGGAGGGCAAGAAAGG;
3', GCGCCCGGGTTAGTTCTTCTCTGGCA) based on the published sequence
including restriction sites, allowing us to insert the PCR product into
pGEX-5X-1 vector (Amersham Biosciences, Oakville, Ontario, Canada). The
full-length Syt I was amplified by PCR using distinct 5' primers, again
based on the published sequence (CGCGAATTCACCATGGACTCCCTTCTGGCG). These
constructs were subsequently excised from pGEX-5X-1 and inserted into enhanced
green fluorescent protein (EGFP)-C2 vectors (Clontech, Palo Alto, CA) using
EcoRI and SmaI. The EGFP-C2 Syt I clones were then excised
by NheI and SmaI and inserted into the Aplysia
expression vector pNEX-3 (Manseau et al.,
2001
) cut with XbaI and SmaI. All pNEX-3
EGFP-Syt I clones were checked by sequencing over their entire length. EGFP
was replaced by enhanced cyan fluorescent protein (ECFP) and enhanced yellow
fluorescent protein (EYFP) (Clontech) using SphI and BsrGI. The
S
A mutant was generated using the Syt I cytoplasmic domain of Syt
IVQ cloned into pGEX-5X-1 or the pNEX-3 EGFP-Syt IVQ in
a two-step mutagenic procedure as described previously
(Manseau et al., 2001
). A new
MluI site was formed in Syt IVQ; S-A mutant. All
constructs were sequenced over the entire amplified region to confirm that no
changes were made. The DsRed VAMP (vesicle-associated membrane protein) was
made using primers based on the published Aplysia VAMP sequence
(Yamasaki et al., 1994
) for
insertion into EGFP-C2 and then insertion into pNEX-3. The EGFP was then
replaced with DsRed (Clontech) with appropriate enzymes.
Quantitative reverse transcription-PCR. The relative amounts of
Syt IVQ and Syt I mRNA was determined by quantitative reverse
transcription (RT)-PCR. RNA isolation was performed using the RNAqueous-4PCR
kit (Ambion, Austin, TX) according to the protocol provided by the
manufacturer. Common forward and reverse primers were used, followed by an
RsaI digest (addition of VQ introduces a new RsaI site into
Syt I DNA sequence). Mixes of plasmids encoding Syt IVQ and Syt I
were used in control reactions as part of each PCR set to generate a standard
curve. The PCR products were subjected to RsaI digest and separated
on agarose gels, illuminated under UV light, digitally scanned, and quantified
using NIH Image.
In vitro phosphorylation assay. Phosphorylation was initiated by
the addition of purified protein kinase C (PKC) Apl II
(Sossin et al., 1996
) to the
phosphorylation mix [50 nM
12-O-tetradecanoylphorbol-13-acetate, 5 µg/ml phosphatidylserine,
500 µM CaCl2, 10 µM ATP, 13
µCi [
-32P]ATP, 45 mM MgCl2, 180
mM Tris, pH 7.5, and various amounts of glutathione
S-transferase (GST) fusion proteins]. Nonphosphorylated controls were
incubated in a control mix (phosphorylation mix without ATP). These reactions
were allowed to proceed at 25°C for 30 min and were stopped by the
addition of 20 µl of Laemmli buffer and then loaded onto 9%
SDS-polyacrylamide gels. After transfer to nitrocellulose, the blots were
exposed to film to visualize the incorporation of radioactive phosphate.
Cell culture preparation. Injections of plasmid DNA and
physiological paradigms were as described previously
(Manseau et al., 2001
). An
arbitrary scale of fluorescence (from 0 to 5) was established to evaluate the
labeling of each sensory neuron (Manseau
et al., 2001
). Sensory neurons that were positive for plasmid
expression (35 on the scale) were individually paired with motor
neurons (kept aside until then in the refrigerator at 4°C to prevent them
from retracting their axons), in a 10% hemolymph-enriched medium. The day
after the pairing, the Petri dish solution was exchanged with fresh 10%
hemolymphL-15. Electrophysiological recordings started on the fifth
day, 2 d after pairing, to allow the formation of new synaptic contacts and a
full maturation of the PKC transduction pathway involved in short-term
plasticity (Sun and Schacher,
1996
). All recordings were done in L-15 at room temperature
(2124°C) using Axoclamp-2A and Axoprobe-1A amplifiers (Axon
Instruments, Foster City, CA) in the current-clamp mode. Membrane resistance
of both sensory and motor neurons and the resting potential of motor neurons
were measured at the start and at the end of each recording. The resting
potential of sensory neurons was not measured until the end of experiment to
prevent the generation of unwanted spikes. The major criterion for selection
of healthy neurons was a stable resting potential. Throughout the experiments,
the sensory neuron was held at -50 mV, and the siphon motor neuron of the LF
cluster, which was impaled first, was hyperpolarized to -80 mV. In experiments
on short-term facilitation of depressed synapses, a hyperpolarizing current
was passed (glass pipette, 1015 M
, filled with 2 M
KAc) to prevent spike generation during the sensory neuron impalement. Short
intracellular pulses were delivered, and, once the threshold for action
potential was reached, the stimulation intensity and interval was kept
constant through the experiment. We continued the experiment when the initial
EPSP amplitude exceeded 2 mV. The series of EPSPs were evoked every 20 sec in
the motor neuron. 5-HT (10 µM final concentration) was added
directly to the bath near the cells and mixed gently after 40 EPSPs. Ten
additional EPSPs were recorded. In another set of cocultures, 12,13-dibutyrate
(PDBu) (100 nM final concentration) was added instead of 5-HT to
determine whether the inhibition of facilitation was before or after PKC
activation.
Changes in synaptic transmission. EPSPs were always normalized to
the size of the initial EPSP. The amount of facilitation was calculated as the
difference between EPSPs after treatment (averages of EPSPs 4143) and
EPSPs before treatment (averages of EPSPs 3840). In experiments on
short-term facilitation of rested synapses, a single depolarizing stimulus was
applied to the sensory neuron, and the initial EPSP amplitude was recorded. At
2 min, 5-HT was applied to the bath (final concentration of 10
µM), and a second EPSP was recorded 3 min later in the presence
of 5-HT. The amount of facilitation was calculated as the difference between
EPSP 2 and EPSP 1 (EPSP 1 normalized to 100%). Data were acquired and analyzed
digitally using CLAMPEX 7 and a modified version of pCLAMP (Axon Instruments)
(Manseau et al., 2001
).
Experiments comparing the effects of the various constructs were always done
in parallel.
Confocal laser microscopy on living cells. The cells were
coinjected with constructs tagged with either ECFP or EYFP and were visualized
with a Zeiss (Jena, Germany) LSM 510 confocal laser microscope. EYFP and ECFP
were chosen because their emission spectra overlap minimally, so they can be
distinguished when used simultaneously. For dual imaging of EYFP- and
ECFP-injected cells, the cells were excited successively with multi-line argon
lasers at 514 and 458 nm, respectively. Images were analyzed using Zeiss LSM
510 software. For EYFP, the cells were light collected through a 530 nm
long-pass emission filter, passing by an infrared 480520 nm bandpass
dichroic mirror. For ECFP, the cells were light collected with a 480520
nm bandpass emission filter. A DsRed-VAMP construct was used as an indicator
for synapse localization. In these experiments, the cells were coinjected with
DsRed and ECFP Syt I or ECFP Syt IVQ. For Ds-Red, the cells were
excited with a heliumneon laser unit at 543 nm and light collected
through a 558583 bandpass filter.
Antibody production and immunoblotting. Antibodies were raised
against a GST fusion protein consisting of the cytoplasmic domain of Syt
IVQ (nucleotides 2791284). The antibodies were affinity
purified using MBP-Syt IVQ fusion proteins encoding the cytoplasmic
domain of Syt I. The MBP Syt I fusion proteins were immobilized on
polyvinylidene difluoride membrane, and Syt I antibody was purified in a
two-step purification procedure as described previously
(Ramjaun et al., 1997
).
We also generated a phospho-specific antibody against a peptide sequence
[CQLLGNS(p)YKEK] from Aplysia Syt I, with serine 123 converted to a
phosphoserine as described previously
(Nakhost et al., 1999
).
Immunoblotting was performed as described previously
(Nakhost et al., 1999
).
 |
Results
|
|---|
Identification of a novel alternatively spliced form of
Aplysia synaptotagmin I
Aplysia Syt I was cloned previously and shares the putative domain
structure of all other Syt isoforms
(Martin et al., 1995
). In the
process of recloning the cytoplasmic domain of Aplysia Syt I, we
identified an alternatively spliced form.
Figure 1A shows the
nucleotide alignment of the published Syt I sequence and our initial Syt I
clone Syt IVQ in the region of the alternative splice. Our sequence
has six additional nucleotides resulting in a VQ insert in the amino acid
sequence. Interestingly, the VQ is also seen in the published sequences of
squid and Drosophila Syt I (Fig.
1B). Searching the Drosophila Expressed Sequence
Tag (EST) database, we found a number of cDNAs that are identical to the
published Syt I but specifically lack the VQ residue
(Fig. 1B). Although we
have not cloned the genomic sequence of Aplysia synaptotagmin,
examination of the Drosophila genome sequence reveals that the VQ
sequence begins an exon of Syt I and thus suggests that alternative exon entry
can explain the alternatively spliced forms. Interestingly, the VQ sequence is
also located at the exon start in the Syt I-related Syt IX (also called Syt V)
(Craxton et al., 1997
).
Alternative exon entry has also been described in this exact region of the
linker region of rat Syt I in which the amino acids ALK are inserted instead
of VQ (Perin et al., 1990
)
[Fig. 1B, Syt I(ALK)].
Syt I, II, and IX are more closely related to each other than to invertebrate
Syt I isoforms, suggesting that they have diverged after the
vertebrateinvertebrate separation
(Marqueze et al., 2000
). The
juxtamembrane domain is well conserved in all Syt-I like isoforms (vertebrate
and invertebrate) but not in other Syts, such as Syt IV
(Fig. 1B). Although
Syt I and Syt II are highly conserved in the juxtamembrane domain, it is also
striking that, in the region of the VQ insertion, Syt II has a sizable
deletion (Fig. 1B).
Thus, there is an alternative exon entry site in the linker domain of Syt I
that is conserved over evolution. However, the role for this splicing is
unknown.

View larger version (52K):
[in this window]
[in a new window]
|
Figure 1. Cloning of a novel spliced isoform of Syt I. A, Nucleotide
sequence of two clones amplified from a nervous system library showing the
insertion of six amino acids. Nucleotide numbering is from residues
303449. B, Alignment of juxtamembrane domain from a number of
species highlighting the conservation of this region in Syt Is and the
conservation of the spliced forms. Drosophila Ib (Dros Ib) (from EST
clones; accession numbers 15484159, 15504610, and 15505802) and Syt
IALK (Perin et al.,
1990 ). Syt IX has also been called Syt V in other publications.
The black bar represents the site of alternative splicing, and the star
represents the site of PKC phosphorylation. C, RT-PCR of Syt I and
Syt IVQ demonstrates approximately equal amounts of both splice
forms. The insertion of the VQ generates an RsaI site. We used PCR
primers flanking the insert for RT-PCR from the Aplysia nervous
system. The amplified product was then cut with RsaI to determine the
proportion of RNAs with the insert. Different amounts of nervous system
template were used to ensure that PCR amplification was in the linear range.
Results are shown for two different animals (NS1 and NS2). To generate a
standard curve, mixes of plasmids containing different proportions of Syt
IVQ and Syt I were used as the template for PCR. D, The
proportion of the two RNAs was calculated based on the standard curves. Values
are mean ± SEM for four independent RT-PCRs from four individual
animals.
|
|
Quantitative reverse transcription (RT-PCR) studies from the
Aplysia nervous system indicate that mRNAs encoding Syt I and Syt
IVQ are present in the nervous system of Aplysia at
approximately a 1:1 ratio (Fig.
1C; quantitated in D). Similar results were
obtained when RT-PCR was done with RNA isolated from sensory neuron clusters
(data not shown). Treatment of sensory clusters with a paradigm that induces
long-term facilitation [5 min pulses for five times each of 20
µM 5-HT (Montarolo et al.,
1986
)] did not alter the ratio of Syt I and Syt IVQ
(percentage change in Syt I/Syt IVQ ratio, -4 ± 6%;
n = 4).
Syt I and Syt IVQ are both localized to synaptic
vesicles
Splicing may effect localization of Syt Is as the juxtamembrane domain has
been implicated in the localization of Syts
(Fukuda et al., 2001
). To test
this, we examined colocalization of the expressed Syt Is with the synaptic
vesicle protein VAMP/synaptobrevin. We coexpressed DsRed-tagged VAMP and
either ECFPSyt IVQ or ECFP-Syt I in sensory neurons and examined
their localization after 5 din coculture with motor neurons. FP-tagged VAMP
has been used to mark synaptic vesicle pools in many systems
(Nonet, 1999
;
Ahmari et al., 2000
), and, in
Aplysia sensory neurons, tagged VAMP colocalizes with antibodies to
clustered glutamate at sensory-to-motor neuron synapses (data not shown). Both
Syt I isoforms are colocalized with VAMP at concentrations of VAMP likely to
mark pools of synaptic vesicles (Fig.
2A,B). This is not surprising because both Syt I and Syt
IVQ contain the putative AP2 (adaptor protein 2) binding site
required for endocytosis into synaptic vesicles
(Zhang et al., 1994
). However,
because the juxtamembrane domain has been postulated to determine sorting from
the trans-Golgi network (Fukuda et al.,
2001
), we examined whether Syt I and Syt IVQ were
always localized together. In these experiments, we used colocalization of
EYFP-Syt I and ECFP-Syt IVQ or ECFP-Syt I and EYFP-Syt
IVQ to control for variations in the intensities of the different
fluorescent proteins. Approximately 5% of punctae contained one or the other
isoform (Fig. 2C),
regardless of the combination of tags, whereas most punctae colocalized
(Fig. 2D). Although
the number of non-colocalized punctae is small, we did not observe any
non-colocalized punctae in control experiments when we examined colocalization
of ECFP-Syt I and EYFP-Syt I or ECFP-Syt IVQ and EYFP-Syt
IVQ (data not shown). The punctae containing only Syt I or only Syt
IVQ may be transport vesicles. The number of these vesicles in
processes is probably small compared with the number of synaptic vesicles. The
localization of ECFP- and EYFP-tagged proteins in the cell bodies was not
possible because of the pigment granules in the cell body that could be seen
even in the absence of injections.

View larger version (59K):
[in this window]
[in a new window]
|
Figure 2. Localization of Syt I and Syt IVQ in sensory neurons. Plasmids
encoding DsRed-labeled Aplysia VAMP and ECFP-labeled Syt I
(A) or DsRed-labeld Aplysia VAMP and ECFP-labeled Syt
IVQ (B) were injected into sensory neurons. Expressing
neurons were then paired with motor neurons and visualized 35 d later.
For five cells expressing Syt I and four cells expressing Syt IVQ,
all DsRed VAMP clusters were completely overlapped with ECFP-Syt I (43
clusters) or ECFP-Syt IVQ (14 clusters). C, Plasmids
encoding ECFP-labeled Syt I and EYFP-labeled Syt IVQ or
ECFP-labeled Syt IVQ and EYFP-labeled Syt I were injected into
sensory neurons. Expressing neurons were then paired with motor neurons and
visualized 35 d later. D, In the majority of images, EYFP Syt
IVQ and ECFP Syt I did completely overlap. Scale bars, 20
µm.
|
|
Syt I and Syt I VQ are both phosphorylated in
vitro by PKC at serine 123
Serine 123 in Aplysia Syt I corresponds to the site phosphorylated
by PKC in vertebrate Syt I (Hilfiker et
al., 1999
) and is located very close to the insertion of VQ
(Fig. 1B). To examine
whether the insertion of VQ affected PKC phosphorylation, we incubated PKC and
PKC activators with GST fusion proteins with the cytoplasmic domain of Syt I,
Syt IVQ, or Syt IVQ with serine 123 converted to alanine
(Syt IVQ; S-A). Although these results confirm that serine 123 is a
conserved PKC site because PKC phosphorylates both Syt I and Syt
IVQ, but not Syt IVQ; S-A
(Fig. 3A), there were
no differences in the in vitro phosphorylation of Syt I and Syt
IVQ (Fig.
3A). Further confirming serine 123 as an in
vitro PKC site, a phospho-specific antibody raised to the serine 123 site
in Aplysia Syt I recognized bacterially expressed Syt I only after
phosphorylation by PKC (Fig.
3B).

View larger version (11K):
[in this window]
[in a new window]
|
Figure 3. Syt I and Syt IVQ are phosphorylated at serine 123 by PKC in
vitro. A, GST fusion proteins (0.15, 0.3, and 0.6 µg)encoding the
intracellular region of Syt IVQ, Syt IVQ; S-A, or Syt I
were incubated with purified PKC Apl II, PKC activators, and radioactive ATP
for 30 min at room temperature. The proteins were separated on 9% SDS-PAGE,
blotted to nitrocellulose, and then stained with Ponceau to visualize the
fusion proteins. The blots were then exposed to radiography to visualize
incorporation of ATP. This experiment was repeated three times with similar
results. B, GST-Syt IVQ (0.6 µg) was incubated with
purified PKCApl II and PKC activators in the presence or absence of
radioactive ATP. The proteins were separated on 9% SDS-PAGE, blotted to
nitrocellulose, and then probed first with a phospho-peptide-specific antibody
raised to the serine 123 site in Syt I. The blot was then stripped and probed
with an antibody raised to a peptide from Syt I. The blot was then exposed to
radiography to visualize incorporation of ATP (Autorad).
|
|
Overexpression of Syt IVQ specifically blocks the
facilitation of depressed synapses upstream of PKC activation
We investigated the physiological role(s) of different Syt I isoforms
in vivo by overexpressing them in Aplysia sensory neurons.
Various plasmids encoding EGFP or EGFP-tagged Syt I constructs (EGFP-Syt I,
EGFP-Syt IVQ, EGFP-Syt IS-A, or EGFP-Syt IVQ;
S-A) were injected into Aplysia sensory neurons, which were
subsequently used to make SM cell cultures. First, we examined the ability of
5-HT to reverse synaptic depression. Synaptic depression was produced by 40
repeated stimulations of the sensory cell. 5-HT (10 µM final
concentration) was added to induce PKC-dependent facilitation
(Ghirardi et al., 1992
). Our
electrophysiological results show that, in cells expressing EGFP-Syt I,
EGFP-Syt IS-A, or EGFP alone, 5-HT-induced facilitation of
depressed SM synapses was normal (Fig. 4
A, B). Injection of plasmids encoding EGFP alone had no
effect on transmitter release or the reversal of synaptic depression in
Aplysia (Manseau et al.,
2001
). Conversely, overexpression of EGFP-Syt IVQ
blocked the facilitating effect of 5-HT
(Fig. 4 A, B).
Overexpression of EGFP-Syt IVQ; S-A also blocked the facilitating
effect of 5-HT but appeared somewhat less effective than EGFP-Syt
IVQ (Fig. 4 A,
B). The difference between EGFP-Syt IVQ and
EGFP-Syt IVQ; S-A became significant when examined a few stimuli
after the 5-HT pulse [amount of facilitation measured using EPSPs (4244
or 4345) EGFP-Syt IVQ vs EGFP-Syt IVQ; S-A;
p < 0.05; Tukey's post hoc test]. This result is not
consistent with Syt IVQ being the PKC substrate that is important
for the reversal of synaptic depression, because, in this case, converting the
serine to ala-nine should reduce the ability to reverse synaptic depression.
Moreover, mutating the serine to alanine in Syt I had no effect on the ability
of 5-HT to reverse depression.

View larger version (16K):
[in this window]
[in a new window]
|
Figure 4. Syt IVQblocks the reversal of synaptic depression at a step
upstream of PKC activation. A, Short-term facilitation of depressed
synapses is blocked by overexpression of Syt IVQ but not Syt I.
Sensory to motor transmission was depressed by a series of 40 repeated
intracellular stimuli (inter-stimulus interval, 20sec), and 5-HT (10
µM) was applied to induce synaptic facilitation, followed by an
additional 10 stimuli. Averaged normalized EPSPs (mean ± SEM) for cells
expressing EGFP (open squares;n = 23), Syt I (open circles;n
= 8),Syt IS-A (filled circles;n = 5), Syt IVQ
(open triangles;n = 19), or Syt I VQ; S-A (filled
triangles; n = 12) are shown. The region around 5-HT addition has
been expanded for clarity below. B, The amount of facilitation was
calculated as the difference between the average of the three normalized EPSPs
after 5-HT and the three normalized EPSPs before 5-HT [ANOVA; p <
0.005; **post hoc Tukey's test showed that Syt
IVQ (p < 0.01) and Syt IVQ; S-A (p
< 0.05) were significantly different from EGFP]. C, Same as in
A, but PDBu (100 nM) was added after the 40th stimuli in
cells expressing EGFP (open squares; n = 4) or Syt IVQ
(filled triangles; n = 6). D, The amount of facilitation was
calculated as the difference between the average of the three normalized EPSPs
after PDBu and the three normalized EPSPs before PDBu. There was no
significant difference between EGFP- and Syt IVQ-expressing cells
(ANOVA;p > 0.5). E, Facilitation of rested SM synapses is
unaffected by overexpression of either Syt I or Syt IVQ. An initial
EPSP was induced by single extracellular stimulation to the sensory neuron.
After 5-HT (10 µM), a second EPSP was recorded. The
interstimulus interval between the two EPSPs was 5 min. The EPSP amplitude was
normalized to the initial control value. Facilitation was determined by
comparing the difference between the two normalized EPSPs [EPSP 2 (after 5-HT)
- EPSP 1 (before 5-HT); EGFP, n = 5; Syt I, n = 8; Syt
IVQ, n = 6]. No significant differences were observed
(ANOVA; p > 0.5).
|
|
Overexpression of EGFP-Syt I, EGFP-Syt IVQ, EGFP-Syt I
S-A, or EGFP-Syt IVQ; S-A did not affect the resting
membrane potential or the rate of synaptic depression
(Table 1). Overexpression of
EGFP-Syt I showed a trend to lower initial EPSPs, although, because of the
large variability in initial EPSPs, this was not significant in an ANOVA
(Table 1). The reduction in
EPSP size is similar to that seen in a previous study in which Syt I was
overexpressed in this system (Martin et
al., 1995
).
View this table:
[in this window]
[in a new window]
|
Table 1. Comparison of intrinsic and synaptic properties of sensory neurons
expressing EGFP or various EGFP-Syt I constructs
| |
Whereas overexpression of EGFP-Syt IVQ significantly decreased
the magnitude of the response to 5-HT in depressed synapses, the kinetics of
the remaining effect of 5-HT was normal
(Fig. 4A). This is in
contrast to what is observed with overexpression of a dominant-negative form
of PKC Apl II, in which the onset of facilitation was considerably delayed as
might be expected for a true dominant-negative effect
(Manseau et al., 2001
). This
suggested that the blockade was not attributable to a competition between
wild-type and overexpressed EGFP-Syt IVQ for PKC phosphorylation,
but instead, that 5-HT does not activate PKC as well in the cells expressing
EGFP-Syt IVQ. To test whether facilitation downstream of PKC was
intact, we examined whether EGFP-Syt IVQ could block the effect of
PDBu, which activates PKC independently of 5-HT. Indeed, EGFP-Syt
IVQ did not block phorbol ester-mediated reversal of synaptic
depression (Fig.
4C,D), suggesting that the deficit lay in the ability of
5-HT to activate PKC. It should be noted that, although PDBu can increase
transmitter release independently of PKC in some systems, the effect of PDBu
on transmitter release at these synapses is blocked by inhibitors of PKC
(Braha et al., 1990
).
To determine whether there was a general deficit in 5-HT-mediated signal
transduction, we looked at the facilitation of nondepressed synapses. This
effect is meditated by 5-HT activation of PKA and not PKC
(Ghirardi et al., 1992
). In
this case, facilitation was not affected by the overexpression of either
EGFP-Syt I or EGFP-Syt IVQ (Fig.
4E). This demonstrates that overexpression of EGFP-Syt
IVQ specifically interferes with the ability of 5-HT to reverse
synaptic depression without generally affecting synaptic transmission or the
ability of 5-HT to activate PKA.
 |
Discussion
|
|---|
We found a novel alternative splice form of Syt I with a two amino acid VQ
insert in the juxtamembrane region that joins the transmembrane region to C2A.
Both Syt I and Syt IVQ are expressed at equal levels. This splicing
is evolutionary well conserved and physiologically significant because
expression of Syt IVQ, but not Syt I, blocked the reversal of
synaptic depression.
A novel but conserved splice form in the juxtamembrane domain of Syt
I
The juxtamembrane region between the transmembrane domain and C2A has not
been studied extensively. Using antibodies for Syt I and Syt IV, Fukuda et al.
(2001
) found that these two
isoforms were localized to distinct subcellular fractions in PC12 cells. Using
chimeras, they showed that the localization signal was in the juxtamembrane
region (Fukuda et al., 2001
).
Whereas invertebrates appear to have only one Syt I-like form, vertebrates
have three isoforms, Syt I, II, and IX. Remarkably, although the juxtamembrane
region of all three vertebrate Syt I-like isoforms is generally conserved,
they are remarkably distinct in the segment in which the VQ splice exists,
suggesting that this may be an important distinction between the different Syt
I-like vertebrate isoforms. Moreover, the conservation of this splicing event
throughout evolution points to an important role for this domain.
Overexpression of Syt IVQ blocks the reversal of
depression mediated by 5-HT, but Syt I is not the PKC substrate important for
the reversal of depression
The evidence that 5-HT mediates the reversal of synaptic depression through
activation of PKC is strongly supported by both pharmacological inhibitors and
activators of PKC and dominant-negative experiments
(Braha et al., 1990
;
Ghirardi et al., 1992
;
Manseau et al., 2001
). Syt I
is a conserved PKC substrate involved in transmitter release, and the
insertion is located quite near the PKC phosphorylation site. Thus, regulation
of PKC phosphorylation represented an attractive step at which insertion of VQ
could regulate Syt I. However, PKC phosphorylation in vitro does not
differentiate between Syt I and Syt IVQ, and Syt IVQ
does not block the reversal of synaptic depression mediated by phorbol esters.
Moreover, the reversal of synaptic depression is not blocked by Syt
IS-A. Thus, the block by Syt IVQ likely acts before PKC
activation. For example, this could be attributable to less available 5-HT
receptors that could activate PKC. Indeed, it has been suggested that these
receptors were variably active early in synapse formation, suggesting that the
receptors may be rate limiting in the ability of 5-HT to reverse synaptic
depression (Sun and Schacher,
1996
).
Interestingly, whereas PKC activity is required for the reversal of
synaptic depression, overexpression of active PKC actually inhibited the
ability of 5-HT to reverse synaptic depression
(Manseau et al., 2001
). This
inhibition appeared kinetically similar to the block by Syt IVQ and
may be attributable to an effect of PKC on regulating the availability of 5-HT
receptors (Manseau et al.,
2001
). Our results would be consistent with Syt IVQ
being the PKC substrate involved in this phenomenon because Syt IVQ;
S-A showed reduced inhibition compared with Syt IVQ.
In summary, we discovered a well conserved splice in the juxtamembrane
region of Syt I. We demonstrated different physiological effects attributable
to overexpression of the two distinct products of this splicing. Our results
demonstrate an important undiscovered role for the juxtamembrane domain of Syt
I.
 |
Footnotes
|
|---|
Received Oct. 17, 2002;
revised May. 13, 2003;
accepted May. 21, 2003.
This work was supported by Natural Sciences and Engineering Research
Council of Canada (NSERC) Grant 187018 (W.S.S.) and Canadian Institutes of
Health Research (CIHR) Grants MOP-12046 (W.S.S.) and MOP-14142 (V.F.C.). A.N.
is supported by an NSERC graduate studentship, and W.S.S. is a Killiam Scholar
and supported by a CIHR Scientist award. We thank Peter McPherson, Ted Fon,
Luc Desgroseillers, and Louis-Eric Trudeau for helpful comments on this
manuscript.
Correspondence should be addressed to Dr. Wayne S. Sossin, Department of
Neurology and Neurosurgery, McGill University, Montreal Neurological
Institute, BT110, 3801 rue University, Montreal, Quebec, Canada H3A2B4.
E-mail:
wayne.sossin{at}mcgill.ca.
Copyright © 2003 Society for Neuroscience
0270-6474/03/236238-07$15.00/0
* A.N. and G.H. contributed equally to this work. 
 |
References
|
|---|
Adolfsen B, Littleton JT (2001) Genetic and molecular
analysis of the synaptotagmin family. Cell Mol Life Sci
58: 393402.[Web of Science][Medline]
Ahmari SE, Buchanan J, Smith SJ (2000) Assembly of
presynaptic active zones from cytoplasmic transport packets. Nat
Neurosci 3:
445451.[Web of Science][Medline]
Bennett MK, Miller KG, Scheller RH (1993) Casein
kinase II phosphorylates the synaptic vesicle protein p65. J
Neurosci 13:
17011707.[Abstract]
Braha O, Dale N, Hochner B, Klein M, Abrams TW, Kandel ER
(1990) Second messengers involved in the two processes of
presynaptic facilitation that contribute to sensitization and dishabituation
in Aplysia sensory neurons. Proc Natl Acad Sci USA
87:
20402044.[Abstract/Free Full Text]
Byrne JH, Kandel ER (1996) Presynaptic facilitation
revisited: state and time dependence. J Neurosci
16: 425435.[Abstract/Free Full Text]
Craxton M, Olsen A, Goedert M (1997) Human
synaptotagmin V (SYT5): sequence, genomic structure, and chromosomal location.
Genomics 42:
165169.[Medline]
Davletov B, Sontag JM, Hata Y, Petrenko AG, Fykse EM, Jahn R,
Sudhof TC (1993) Phosphorylation of synaptotagmin I by casein
kinase II. J Biol Chem 268:
68166822.[Abstract/Free Full Text]
DiAntonio A, Schwarz TL (1994) The effect on synaptic
physiology of synaptotagmin mutations in Drosophila.
Neuron 12:
909920.[Web of Science][Medline]
Fernandez-Chacon R, Konigstorfer A, Gerber SH, Garcia J, Matos MF,
Stevens CF, Brose N, Rizo J, Rosenmund C, Sudhof TC (2001)
Synaptotagmin I functions as a calcium regulator of release probability.
Nature 410:
4149.[Medline]
Fukuda M, Ibata K, Mikoshiba K (2001) A unique spacer
domain of synaptotagmin IV is essential for Golgi localization. J
Neurochem 77:
730740.[Web of Science][Medline]
Geppert M, Goda Y, Hammer RE, Li C, Rosahl TW, Stevens CF, Sudhof
TC (1994) Synaptotagmin I: a major Ca 2+
sensor for transmitter release at a central synapse. Cell
79: 717727.[Web of Science][Medline]
Ghirardi M, Braha O, Hochner B, Montarolo PG, Kandel ER, Dale N
(1992) Roles of PKA and PKC in facilitation of evoked and
spontaneous transmitter release at depressed and nondepressed synapses in
Aplysia sensory neurons. Neuron
9: 479489.[Web of Science][Medline]
Hilfiker S, Pieribone VA, Nordstedt C, Greengard P, Czernik AJ
(1999) Regulation of synaptotagmin I phosphorylation by multiple
protein kinases. J Neurochem 73:
921932.[Medline]
Mackler JM, Drummond JA, Loewen CA, Robinson IM, Reist NE
(2002) The C2BCa 2+-binding motif of
synaptotagmin is required for synaptic transmission in vivo.
Nature 418:
340344.[Medline]
Manseau F, Fan X, Hueftlein T, Sossin WS, Castellucci VF
(2001) Ca 2+-independent PKC Apl II
mediates the serotonin induced facilitation at depressed synapses in
Aplysia. J Neurosci 21:
12471256.[Abstract/Free Full Text]
Marqueze B, Berton F, Seagar M (2000) Synaptotagmins
in membrane traffic: which vesicles do the tagmins tag?
Biochimie 82:
409420.[Medline]
Martin KC, Hu Y, Armitage BA, Siegelbaum SA, Kandel ER, Kaang BK
(1995) Evidence for synaptotagmin as an inhibitory clamp on
synaptic vesicle release in Aplysia neurons. Proc Natl Acad
Sci USA 92:
1130711311.[Abstract/Free Full Text]
Montarolo PG, Goelet P, Castellucci VF, Morgan J, Kandel ER,
Schacher S (1986) A critical period for macromolecular synthesis
in long-term heterosynaptic facilitation in Aplysia.
Science 234:
12491254.[Abstract/Free Full Text]
Nakhost A, Dyer JR, Pepio AM, Fan X, Sossin WS (1999)
Protein kinase C phosphorylated at a conserved threonine is retained in the
cytoplasm. J Biol Chem 274:
2894428949.[Abstract/Free Full Text]
Nonet ML (1999) Visualization of synaptic
specializations in live C. elegans with synaptic vesicle protein-GFP
fusions. J Neurosci Methods 89:
3340.[Web of Science][Medline]
Nonet ML, Grundahl K, Meyer BJ, Rand JB (1993)
Synaptic function is impaired but not eliminated in C. elegans
mutants lacking synaptotagmin. Cell 73:
12911305.[Web of Science][Medline]
Perin MS, Fried VA, Mignery GA, Jahn R, Sudhof TC
(1990) Phospholipid binding by a synaptic vesicle protein
homologous to the regulatory region of protein kinase C. Nature
345:
260263.[Medline]
Ramjaun AR, Micheva KD, Bouchelet I, McPherson PS
(1997) Identification and characterization of a nerve
terminal-enriched amphiphysin isoform. J Biol Chem
272:
1670016706.[Abstract/Free Full Text]
Schiavo G, Osborne SL, Sgouros JG (1998)
Synaptotagmins: more isoforms than functions? Biochem Biophys Res
Commum 248:
18.[Web of Science][Medline]
Sossin WS, Fan XT, Saberi F (1996) Expression and
characterization of Aplysia protein kinase C: a negative regulatory
role for the E region. J Neurosci 16:
1018.[Abstract/Free Full Text]
Sudhof TC (2002) Synaptotagmins: why so many? J
Biol Chem 277:
76297632.[Free Full Text]
Sun ZY, Schacher S (1996) Development of short-term
heterosynaptic facilitation at Aplysia sensorimotor synapses in vitro
is accompanied by changes in the functional expression of presynaptic
serotonin receptors. J Neurophysiol 76:
22502261.[Abstract/Free Full Text]
Yamasaki S, Hu Y, Binz T, Kalkuhl A, Kurazono H, Tamura T, Jahn R,
Kandel E, Niemann H (1994) Synaptobrevin/vesicle-associated
membrane protein (VAMP) of Aplysia californica: structure and
proteolysis by tetanus toxin and botulinal neurotoxins type D and F.
Proc Natl Acad Sci USA 91:
46884692.[Abstract/Free Full Text]
Zhang JZ, Davletov BA, Sudhof TC, Anderson RG (1994)
Synaptotagmin I is a high affinity receptor for clathrin AP-2: implications
for membrane recycling. Cell 78:
751760.[Web of Science][Medline]
This article has been cited by other articles:

|
 |

|
 |
 
J. Lv, Y. Yang, H. Yin, F. Chu, H. Wang, W. Zhang, Y. Zhang, and Y. Jin
Molecular Determinants and Evolutionary Dynamics of Wobble Splicing
Mol. Biol. Evol.,
May 1, 2009;
26(5):
1081 - 1092.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-Y. Hu, Y. Chen, and S. Schacher
Protein Kinase C Regulates Local Synthesis and Secretion of a Neuropeptide Required for Activity-Dependent Long-Term Synaptic Plasticity
J. Neurosci.,
August 15, 2007;
27(33):
8927 - 8939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Houeland, A. Nakhost, W. S. Sossin, and V. F. Castellucci
PKC Modulation of Transmitter Release by SNAP-25 at Sensory-to-Motor Synapses in Aplysia
J Neurophysiol,
January 1, 2007;
97(1):
134 - 143.
[Abstract]
[Full Text]
[PDF]
|
 |
|